Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT00593944 · COMPLETED

Trial details

NCT number: NCT00593944
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2008-08-01
Primary completion: 2010-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.